Apatinib Plus Camrelizumab in Patients With Previously Treated Advanced Biliary Tract Cancer
Clinical trial NCT04642664 · COMPLETED
Trial details
- NCT number
- NCT04642664
- Sponsor
- Peking Union Medical College Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-01
- Primary completion
- 2020-12-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.